Viridian Therapeutics Inc (VRDN)
13.90
-0.01
(-0.07%)
USD |
NASDAQ |
May 10, 16:00
13.88
-0.02
(-0.14%)
After-Hours: 20:00
Viridian Therapeutics Profit Margin (Quarterly): -67.42K% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -67.42K% |
| December 31, 2023 | -92.86K% |
| September 30, 2023 | -66.19K% |
| June 30, 2023 | -76.48K% |
| March 31, 2023 | -69.54K% |
| December 31, 2022 | -43.60K% |
| September 30, 2022 | -2.42K% |
| June 30, 2022 | -11.52K% |
| March 31, 2022 | -11.89K% |
| December 31, 2021 | -13.53K% |
| September 30, 2021 | -6.75K% |
| June 30, 2021 | -1.65K% |
| March 31, 2021 | -1.27K% |
| December 31, 2020 | -168.0K% |
| September 30, 2020 | |
| June 30, 2020 | -3.83K% |
| March 31, 2020 | -971.5% |
| December 31, 2019 | -1.15K% |
| September 30, 2019 | -1.62K% |
| June 30, 2019 | -353.9% |
| March 31, 2019 | -3.13K% |
| December 31, 2018 | -2.17K% |
| September 30, 2018 | -954.6% |
| Date | Value |
|---|---|
| June 30, 2018 | -399.4% |
| March 31, 2018 | -97.43% |
| December 31, 2017 | -535.7% |
| September 30, 2017 | -357.7% |
| June 30, 2017 | -1.02K% |
| March 31, 2017 | -1.51K% |
| December 31, 2016 | -736.8% |
| September 30, 2016 | -206.9% |
| June 30, 2016 | -286.8% |
| March 31, 2016 | -337.2% |
| December 31, 2015 | -452.2% |
| September 30, 2015 | -629.1% |
| June 30, 2015 | -349.0% |
| March 31, 2015 | -408.4% |
| December 31, 2014 | -344.7% |
| September 30, 2014 | -125.8% |
| June 30, 2014 | -258.2% |
| March 31, 2014 | -64.71% |
| December 31, 2013 | -18.67% |
| September 30, 2013 | -89.43% |
| June 30, 2013 | -48.93% |
| March 31, 2013 | -47.14% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-168.0K%
Minimum
Dec 2020
-353.9%
Maximum
Jun 2019
-33.74K%
Average
-11.52K%
Median
Jun 2022
Profit Margin (Quarterly) Benchmarks
| Perspective Therapeutics Inc | -- |
| Electromed Inc | 10.76% |
| Xtant Medical Holdings Inc | -15.31% |
| Asensus Surgical Inc | -317.3% |
| Myomo Inc | -51.72% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -55.23% |
| Return on Assets | -49.85% |
| Return on Invested Capital | -53.35% |
| Operating Margin (Quarterly) | -77.63K% |
| Return on Net Operating Assets | -6.21K% |